Navigating EUDR Compliance with Ansell: Impact on the MedTech Supply Chain

🌍 Why EUDR Matters to you 

The European Union Deforestation Regulation (EUDR) aims to combat global deforestation by requiring companies to ensure that their supply chains do not contribute to deforestation or forest degradation. While this regulation is enforced within the EU, its effects reach corporations operating there even if US-based. 

For Medical Devices spanning Classes I, II & III this means: 

• Starting Dec 28th 2024, affected companies must demonstrate adherence to several obligations regarding Due Diligence, Traceability and Reporting for certain products including rubber (gloves, tubing, stoppers, plungers, diaphragms…) and wood/paper (single-use devices, packaging, IFUs…). 

• Supply Chain Scrutiny: Even if you don’t operate in the EU, your suppliers may be subject to EUDR, impacting your supply chain and operations. 

• Increased Compliance Costs: Companies may face higher costs related to verifying and documenting the sustainability of their raw materials. 

• Market Access: Compliance with EUDR can be crucial for accessing EU markets and maintaining a competitive edge globally. 

🔍 What You Will Learn 

• EUDR Overview: Key insights from a legal expert on compliance and its impact on global healthcare supply chains. 

• Our Solution in Action: Patrick Lanz will explain how osapiens HUB simplifies EUDR compliance. 

• Ansell’s Journey: Indiana de Seze (below) will share challenges faced by Ansell due to EUDR, and their industry viewpoint.